Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

3

Revenue 2014

Roche

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Roche's 2013 sales performance.

AZ tweaks immuno-oncology trials as it chases lung cancer leaders

AZ tweaks immuno-oncology trials as it chases lung cancer leaders

Meanwhile, third PD-1/PD-L1 inhibitor entrant Roche's Tecentriq (atezolizumab) has been approved for second-line NSCLC and is in phase III trials ongoing as a first-line monotherapy

Merck's Keytruda muscles further ahead of rivals in lung cancer

Merck's Keytruda muscles further ahead of rivals in lung cancer Among these, Roche's Tecentriq (atezolizumab) is the nearest competitor having been approved for second-line NSCLC last October and with phase III trials ongoing as a first-line therapy alone ... BMS - both of which are developing dual immuno-oncology

Former AZ oncology head joins Innate Pharma

Former AZ oncology head joins Innate Pharma Prior to this, he was senior vice president of global product strategy at Roche's Genentech unit, and has also held senior positions in oncology at Aventis and Sanofi.

Takeda agrees $5.2bn deal to buy Ariad

Takeda agrees $5.2bn deal to buy Ariad The drug has breakthrough status in that indication from the FDA but will have to compete in the second-line setting with Novartis' Zykadia (ceritinib) and Roche's  Alecensa (alectinib).

Neurodegenerative disorders market set to reach $45bn by 2022

Neurodegenerative disorders market set to reach $45bn by 2022 Among these, are Roche's Ocrevus (ocrelizumab) for multiple sclerosis (MS) and Celgene's ozanimod for relapsed MS, with both firms predicted to become major market players.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Roche
Global revenue 2014
1: Novartis
2: Pfizer
3: Roche
4: Sanofi
5: Merck & Co.
6: Johnson & Johnson
7: GlaxoSmithKline
8: AstraZeneca
9: Gilead Sciences
10: Takeda
11: AbbVie
12: Amgen
13: Teva
14: Lilly
15: Bristol-Myers Squibb
16: Bayer
17: Novo Nordisk
18: Astellas
19: Boehringer Ingelheim
20: Actavis
21: Otsuka
22: Daiichi Sankyo
23: Biogen Idec
24: Baxter
25: Merck KGaA
US revenue 2014
1: Gilead Sciences
2: Johnson & Johnson
3: Pfizer
4: Roche
5: Novartis
6: Amgen
7: Merck & Co.
8: Sanofi
9: AbbVie
10: Actavis
11: AstraZeneca
12: GlaxoSmithKline
13: Lilly
14: Bristol-Myers Squibb
15: Novo Nordisk
Oncology revenue 2014
1: Roche
2: Novartis
3: Celgene
4: Johnson & Johnson
5: Bristol-Myers Squibb
6: Lilly
7: Takeda
8: AstraZeneca
9: Merck & Co.
10: Amgen
11: Pfizer
12: Astellas
13: Bayer
14: Otsuka
15: Sanofi
16: Merck KGaA
17: Eisai
18: AbbVie
19: Pharmacyclics
20: Incyte
Immunology revenue 2014
1: AbbVie
2: Johnson & Johnson
3: Pfizer
4: Amgen
5: Merck & Co.
6: Astellas
7: Roche
8: Novartis
9: Bristol-Myers Squibb
10: Mitsubishi Tanabe
11: UCB
12: Hisamitsu
13: Daiichi Sankyo
14: Takeda
Cardiovascular revenue 2014
1: AstraZeneca
2: Sanofi
3: Merck & Co.
4: Daiichi Sankyo
5: Pfizer
6: Novartis
7: Bayer
8: Takeda
9: Boehringer Ingelheim
10: Astellas
11: Actelion
12: Johnson & Johnson
13: Shionogi
14: United Therapeutics
15: Bristol-Myers Squibb
16: Gilead Sciences
17: Otsuka
18: Roche
19: Lilly
20: The Medicines Company
Biologic revenue 2014
1: Roche
2: Amgen
3: Novo Nordisk
4: AbbVie
5: Sanofi
6: Johnson & Johnson
7: Pfizer
8: Merck & Co.
9: Lilly
10: Biogen Idec
11: Merck KGaA
12: GlaxoSmithKline
13: Bristol-Myers Squibb
14: Novartis
15: Bayer

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Market access in Europe: balancing access and affordability
European governments continue to pursue national agendas for market access, while also exploring opportunities to work together to achieve lower prices for new drugs...
Introduction to the manufacturing of biologics
The last decade has seen the rapid growth of biologics in the pharma market, making them a key sector to watch. With their growing popularity, it’s important to understand the...
CES 2017 – Medical Device Top Picks
Connected tech was the overriding theme at this year's Consumer Electronics Show in Las Vegas. But among all that consumer gadgetry, there were some great medical devices too. So what...

Infographics